PACTR201803003169385尚未招募Unknown
Erythropoietin as a prophylactic measure against anemia in critically ill patients: A Combined Prospective and Retrospective Study.
Asmaa Fawzy Amer0 个研究点目标入组 100 人开始时间: 2018年3月7日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 65 Year(s)（—）
- 性别
- All
入选标准
- •Critically ill patients
- •aged more than 18 y
- •of both sex
- •who can tolerate enteral feeding with full-calorie within 48 hours after admission to ICU
- •with Hematocrit more than 38%,
- •without vit B12 , folate ,iron deficiency at time of admission
排除标准
- •Pregnancy or lactation,
- •Active bleeding,
- •Presence of any primary hematologic disease.
- •Subjects prohibited from receiving blood transfusions.
- •Recent thromboembolic disease (within 6 months)
- •Chronic renal failure .
- •Liver failure .
- •Recent cytotoxic or immunosuppressive therapy (within 1 month).
- •patients who cannot tolerate enteral feeding throughout period of study
研究者
相似试验
尚未招募
3 期
Erythropoietin in perinatal asphyxiaCTRI/2023/06/053547Sawai man singh medical college and attached hospitals
已完成
不适用
Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgeryNL-OMON40254Catharina-ziekenhuis100
进行中（未招募）
不适用
Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgeryPatients (male and female) scheduled for coronary artery bypass grafting surgery (CABG) or single Aortic Valve replacement (AVR) on conventional cardiopulmonary bypass.EUCTR2012-002076-14-NL100
已完成
3 期
The efficacy of erythropoietin in the treatment of anemia in patients hospitalized in Intensive Care Unit(ICU)Anaemia.Anaemia, unspecifiedIRCT2014071718517N1Vice Chancellor for research of Ardabil University of Medical Sciences70
尚未招募
Unknown
To assess the effect of erythropoietin (EPO)in augmentation of peri implant tissues.CTRI/2023/08/056074one